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Pseudohypoaldosteronism type II (PHAII) is caused by
mutations in the WNK1 and WNK4 genes (WNK with-no-
lysine kinase). In a mouse model of this disease where a
mutant of Wnk4 D561A was knocked in, increased
phosphorylation of the sodium chloride cotransporter (NCC)
was found and the transporter was concentrated on the
apical membrane of the distal tubules. In addition, we
recently found that other kinases, such as the oxidative stress
response kinase-1/STE20/SPS1-related proline alanine–rich
kinase (OSR1/SPAK), also showed increased phosphorylation
in these mice. Here we determined whether this kinase
cascade is regulated by dietary salt intake. We found that the
phosphorylation states of NCC and OSR1/SPAK were
increased by low-salt diets and decreased by high-salt diets; a
regulation completely lost in the knock-in mice. Increased
phosphorylation was reversed by spironolactone and this
decreased phosphorylation was reversed by administration
of exogenous aldosterone. These studies suggest that that
the WNK-OSR1/SPAK-NCC cascade may be a novel effector
system of aldosterone action in the kidney.
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Pseudohypoaldosteronism type II (PHAII) is an autosomal-
dominant disorder characterized by hyperkalemia, acidosis,
and hypertension.1,2 Studies of monogenetic hypertensive
diseases such as PHAII will provide insight into the
mechanisms underlying blood pressure regulation. Pre-
viously, identification of the pathogenesis of Liddle syn-
drome, a monogenic hypertensive disease, greatly improved
our understanding of Na transport in the distal nephron in
the kidney.3 In 2001, mutations in the with-no-lysine kinase 1
(WNK1) and WNK4 genes4 were shown to cause PHAII.5
Several transporters and channels and paracellular chloride
transport were reported to be regulated by the WNK
kinases;6–13 however, a definite conclusion regarding the
pathogenesis of PHAII was not obtained by using hetero-
logous overexpression systems. However, all the phenotypes
of PHAII observed in the mutant WNK4 transgenic mice
were reported to be corrected when the mice were crossed
with sodium chloride (NaCl) cotransporter (NCC) knockout
mice.14 Recently, we generated the Wnk4D561A knock-in mice,
an ideal mouse model of PHAII, and found that the
PHAII phenotypes were corrected by thiazide treatment.15
These results clearly suggest that NCC is the sole
target molecule of WNK4 in the pathogenesis of PHAII.
Furthermore, we clearly showed that the major pathogenesis
of PHAII is the activation of the phosphorylation cascade of
the oxidative stress response kinase-1/STE20/SPS1-related
proline alanine-rich kinase (OSR1/SPAK)-NCC by the
mutant WNK4. Before the study of Wnk4D561A knock-in
mice, OSR1/SPAK kinases had been identified as substrates
for WNK kinases16,17 and phosphorylated NCC.17 However,
we were unable to reconstitute the signal cascade from
WNK4 to NCC by overexpression of these four proteins in
cultured cells or Xenopus oocytes, implying that this
phosphorylation cascade may require additional proteins to
be fully functional.
The purpose of the present study was to determine if
this phosphorylation cascade is not only involved in
the pathogenesis of PHAII but also if it is regulated by
different NaCl intake. We measured the phosphorylation
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status of OSR1/SPAK and NCC in mice that were fed a
normal diet, a high-NaCl diet, or a low-NaCl diet. We also
investigated whether aldosterone was involved in the
regulation of the WNK-OSR1/SPAK-NCC phosphorylation
cascade.
RESULTS
WNK1 and WNK4 protein levels in the kidneys of mice
fed different levels of dietary sodium
We fed wild-type mice and Wnk4D561A knock-in mice
a normal diet (0.4% NaCl), a high-NaCl diet (4.0% NaCl) or
a low-NaCl diet (0.01% NaCl) for 10 days. To verify that the
mice were adapted to each diet, we measured the aldosterone
levels. High-salt diets decreased the aldosterone level, and
low-salt diets increased the aldosterone level in both wild-type
and Wnk4D561A knock-in mice (Figure 1). Serum potassium
levels were not affected by these diets (wild-type mice: normal
diet, 4.0±0.2 mEq/l; low-NaCl diet, 3.9±0.3 mEq/l; high-NaCl
diet, 4.2±0.3 mEq/l. Knock-in mice: normal diet,
4.7±0.3 mEq/l; low-NaCl diet, 4.6±0.3 mEq/l; high-NaCl diet,
4.9±0.3 mEq/l. Mean±s.e.m.; n¼ 8).
We first checked whether different levels of dietary NaCl
affected the protein levels of WNK1 and WNK4 in the
kidneys, as a previous report showed that dietary salt intake
slightly changed the mRNA levels of WNK1 and WNK4.18
However, the protein levels of WNK1 and WNK4 in both
wild-type and Wnk4D561A knock-in mice were unchanged by
different levels of dietary NaCl (Figure 2).
Regulated phosphorylation of the OSR1 and SPAK kinases
by different levels of dietary NaCl
We next measured the levels of total and phosphorylated
OSR1 and SPAK by immunoblotting, as shown previously.15
In wild-type mice, the levels of phosphorylated OSR1 and
SPAK were significantly increased by the low-salt diet and
decreased by the high-salt diet, although the total amounts of
OSR1 and SPAK were unchanged (Figure 3). As we showed
previously,15 the phosphorylation of OSR1 and SPAK was
increased in the Wnk4D561A knock-in mice compared with
the wild-type mice. This increased level of phosphorylation
remained constant irrespective of the different levels of
dietary NaCl (Figure 3).
Regulated phosphorylation of NCC by different levels of
dietary NaCl
Next, we checked the phosphorylation status of NCC. In
addition to the previously established antiphosphorylated
NCC antibody (p-Ser71),15 we generated two additional
antibodies recognizing potential NCC phosphorylation sites
(Thr53 and Thr58) (Supplementary Figure 1). As previously
reported,19 the total amount of NCC protein in wild-type
mice was increased by a low-salt diet and decreased by a
high-salt diet (Figure 4). The phosphorylation of NCC at all
three sites was also increased by a low-salt diet and decreased
by a high-salt diet. Even after correcting for the total amount
of NCC, the phosphorylation of NCC was significantly
regulated by diets with different amounts of salt (bar graphs
in Figure 4). In the Wnk4D561A knock-in mice, however, the
phosphorylation of NCC was increased compared with wild-
type mice, and the increased phosphorylation was not
regulated by the dietary NaCl intake (Figure 4). The
regulation of NCC phosphorylation by different levels of
NaCl in the diets of wild-type mice was also observed by
immunofluorescence microscopy (Figure 5). As we showed
previously,15 the signal for phosphorylated NCC in wild-type
mice was much weaker than that in Wnk4D561A knock-in
mice. This weak signal was further decreased by a high-salt
diet, but significantly increased by a low-salt diet. Although
immunofluorescence of p-OSR1/SPAK was also performed,
the changes mediated by different NaCl diets were too small
to detect by immunofluorescence (Supplementary Figure 2).
However, most of the p-OSR1/SPAK was confirmed to be
present in NCC-expressing nephron segments.
Effect of exogenous infusion of aldosterone and spironolac-
tone on the levels of phosphorylation of OSR1/SPAK and NCC
Finally, we investigated whether aldosterone is involved in the
regulation shown in Figure 4. As the levels of aldosterone
appeared to be correlated with the phosphorylation of these
proteins (Figures 1, 3, and 4), we administered exogenous
aldosterone (0.07 mg/kg/day)20,21 to wild-type mice fed a
high-salt diet (mice with low aldosterone levels) and
spironolactone (20 mg/kg/day)20 to wild-type mice fed a
low-salt diet (mice with high aldosterone levels) to determine
if these agents corrected the decreased and increased
phosphorylation, respectively. The level of aldosterone during
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Figure 1 | Aldosterone levels in mice fed normal-, high-, and low-NaCl diets. High- and low-NaCl diets decreased and increased the
aldosterone level, respectively, in both wild-type and Wnk4D561A knock-in mice. *Po0.05. Values are mean±s.e.m., n¼ 5.
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exogenous aldosterone infusion was 1245±244 pg/ml
(mean±s.e.m., n¼ 5), a level compatible with the levels in
mice fed a low-salt diet (Figure 1). As shown in Figure 6 and
Supplementary Figure 3, exogenous aldosterone increased
phosphorylation and spironolactone decreased phosphoryla-
tion of OSR1/SPAK and NCC at all three sites. This result
indicates that the regulation of OSR1/SPAK and NCC
phosphorylation by dietary salt intake is regulated by
aldosterone.
DISCUSSION
The present study clearly shows that phosphorylation of
OSR1/SPAK and NCC is dynamically regulated by dietary salt
intake in wild-type mice but that the regulation is lost in
Wnk4D561A knock-in mice. These results indicate that the lack
of a feedback mechanism in Wnk4D561A knock-in mice, that
is, the constitutive activation of NCC by phosphorylation
even under a volume-expanded condition, is a major cause of
hypertension in PHAII. In fact, fractional excretion of Na is
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Figure 2 | Protein levels of WNK kinases in mice fed diets with different amounts of salt. Representative immunoblots of WNK1
and WNK4 in the kidneys of wild-type and Wnk4D561A knock-in mice fed diets with different amounts of salt. The protein levels of WNK1 and
WNK4 in both wild-type and Wnk4D561A knock-in mice were not changed by diets with different amounts of salt. Values (mean±s.e.m.,
n¼ 5) are expressed as the percent of values in a normal diet.
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Figure 3 | Regulation of OSR1 and SPAK phosphorylation by diets with different amounts of salt. Representative immunoblots of total
and phosphorylated OSR1/SPAK in the kidneys of wild-type and Wnk4D561A knock-in mice fed diets with different amounts of salt. In both
wild-type and Wnk4D561A knock-in mice, the total protein levels of OSR1/SPAK were unchanged by different amounts of dietary salt.
However, the phosphorylation of OSR1/SPAK in wild-type mice was decreased by a high-salt diet and increased by a low-salt diet. In
contrast, the phosphorylation of OSR1/SPAK in Wnk4D561A knock-in mice was not significantly regulated by different levels of NaCl in the
diet. When collecting the signal data for total OSR1 and SPAK, the band densities of the upper and lower bands in each doublet were
combined. Values (mean±s.e.m., n¼ 5) are expressed as the percent of values in a normal diet. *Po0.05. The identity of bands detected
between p-OSR1 and p-SPAK, especially in the knock-in mice fed a high-salt diet, remain to be determined, although they disappeared after
the antigen absorption test.
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significantly lower in Wnk4D561A knock-in mice after acute
loading of NaCl,15 suggesting that an impaired WNK4-OSR1/
SPAK-NCC cascade might affect the normal salt balance. In
addition, this study clarifies that the WNK-OSR1/SPAK-NCC
cascade is a novel effector system of aldosterone in the
kidney. Thus far, the serum and glucocorticoid kinase
(SGK)–epithelial sodium channel (ENaC) signal cascade has
been identified as the sole effector system of aldosterone in
the kidney. We propose that WNK-OSR1/SPAK-NCC is
another novel effector system of aldosterone (Figure 7). The
amount of NaCl reabsorption in the early distal convoluted
tubules through NCC was shown to be as high as that in the
late distal tubules through ENaC.24 Accordingly, the WNK-
OSR1/SPAK-NCC system may be physiologically as impor-
tant as SGK-Nedd4-ENaC in regulating NaCl reabsorption.
The data from the present study also provide experimental
grounds for the use of thiazide diuretics (NCC inhibitor) to
increase Na excretion in patients receiving loop diuretics and
patients with secondary hyperaldosteronism.
In terms of regulating NaCl reabsorption in the kidney,
cooperation between the WNK-OSR1/SPAK-NCC system
and the SGK-Nedd4-ENaC system under the regulation of
aldosterone is reasonable. However, for potassium homeo-
stasis, the activation of NCC and ENaC causes opposite
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Figure 4 | Regulation of NCC phosphorylation by diets with different amounts of salt. Representative immunoblots of total and
phosphorylated NCC in the kidneys of wild-type and Wnk4D561A knock-in mice fed diets with different amounts of salt. In the wild-type mice,
phosphorylation of NCC at all three sites was dramatically regulated by different amounts of salt in the diet; the phosphorylation was
decreased by a high-salt diet and increased by a low-salt diet. In contrast, the phosphorylation of NCC in Wnk4D561A knock-in mice was not
regulated by different amounts of salt in the diet. Signals of phosphorylated NCC in the bar graphs were corrected by signals of total NCC
(the band densities of p-NCC divided by the densities of total NCC were compared). Values (mean±s.e.m., n¼ 5) are expressed as the
percent of values in a normal diet. *Po0.05.
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effects on potassium excretion, like hyperkalemia in PHAII
and hypokalemia in Liddle syndrome. Accordingly, the
potassium level itself may possibly regulate the WNK-
OSR1/SPAK-NCC system. The level of NCC phosphorylation
from a low-salt diet was still lower than that in Wnk4D561A
knock-in mice, and the wild-type mice fed a low-salt diet did
not actually develop hyperkalemia. We do not know whether
these observations are a result of a feedback system to avoid
hyperkalemia or just the result of a relatively mild activation
of the WNK-OSR1/SPAK-NCC system by low dietary NaCl
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Figure 5 | Immunofluorescence of phosphorylated NCC in the cortex. The signal for phosphorylated NCC at Ser71 in wild-type mice was
decreased by a high-NaCl diet and increased by a low-NaCl diet, which resulted in a signal that was still lower than the signal in Wnk4D561A
knock-in mice. Bar¼ 25 mM. The immunofluorescence of p-OSR1/SPAK is shown in Supplementary Figure 3.
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Figure 6 | Effect of aldosterone and spironolactone on OSR1/SPAK and NCC phosphorylation in wild-type mice. Representative
immunoblots of phosphorylated OSR1/SPAK and NCC in the kidneys of wild-type mice. The decreased phosphorylation of OSR1/SPAK and
NCC at Ser71 resulting from a high-salt diet was restored by exogenous aldosterone, and the corresponding increases in phosphorylation by
a low-salt diet were decreased by spironolactone. Phosphorylation at T53 and T58 showed similar changes (Supplementary Figure 4).
Signals for phosphorylated NCC in the bar graphs were corrected by signals for total NCC. Values (mean±s.e.m., n¼ 5) are expressed as the
percent of values in a normal diet. *Po0.05.
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intake compared with the strong activation observed in
Wnk4D561A knock-in mice. Further studies with different
levels of potassium in the diet may be necessary to answer
this question.
The mechanism used by aldosterone to regulate the WNK-
OSR1/SPAK-NCC cascade is unknown. Considering the
evidence that WNK1 and WNK4 bind to, phosphorylate
and activate OSR1/SPAK,16,17,25,26 and that the level of OSR1/
NCC phosphorylation was greatly increased in Wnk4D561A
knock-in mice,15 it is highly likely that WNK4 and/or WNK1
is an upstream regulator for OSR1/SPAK in vivo. Accordingly,
WNK may be located between aldosterone and OSR1/SPAK
in the signaling cascade. Ring et al.23 recently reported that
WNK4 was phosphorylated at serine 1169 by SGK1. In this
respect, WNK4 may also be a downstream target of SGK in
the regulation by aldosterone, as shown in Figure 7. It is
presently unclear how the data by Lifton and Ellison’s
groups22,27 are related to the schema presented in Figure 7, as
their scheme on NCC regulation by WNK was depicted in the
absence of OSR1/SPAK and most of their studies were
performed in a heterologous overexpression system in
Xenopus oocytes. In their scheme, wild-type WNK4 is a
negative regulator for NCC, WNK1 lies upstream of WNK4
and suppresses this inhibitory effect of WNK4, and WNK3
stimulates NCC activity (for more details, see recent review
by McCormick et al.28). The most critical issue may be
whether or not wild-type WNK4 is a negative regulator for
NCC in vivo. In the initial reports describing WNK4 effect on
NCC by Lifton and Ellison’s groups,6,8 wild-type WNK4
inhibits NCC activity, and one of the mutants lacked this
negative effect. Accordingly, they speculated that the
pathogenesis of PHAII might come from a loss-of-function
effect of the mutant. However, their mutant WNK4
transgenic mice carrying two additional mutant WNK4
alleles showed the PHAII phenotype,14 clearly indicating that
the mutant WNK4 acts as a ‘gain-of-function’ rather than a
‘loss-of-function’ mutant. Our in vitro assay also showed that
wild-type WNK4 increased the phosphorylation OSR1/SPAK
as well as WNK1,17 suggesting that wild-type WNK4 may be
a positive regulator for NCC in vivo. As Richardson et al.29
recently pointed out, the analysis of mice deficient in
different WNK isoforms may be necessary to resolve these
issues.
In summary, the WNK-OSR1/SPAK-NCC phosphoryla-
tion cascade is a novel aldosterone-dependent system. WNK
and OSR1/SPAK themselves, as well as their unknown
regulators, will be promising targets for antihypertensive
drugs.
METHODS
Animal study
Wnk4þ /þ and Wnk4D561A/þ mice (12-week old; n¼ 5)15 were fed a
normal diet (0. 4% NaCl (w/w)), a high-NaCl diet (4.0% NaCl (w/
w)) or a low-NaCl diet (0.01% NaCl (w/w)) and plain drinking
water ad libitum for 10 days. Aldosterone was administered by an
osmotic mini pump (0.07 mg/kg/day).20,21 Control mice received
vehicle (9% ethanol, 87% propylene glycol, and 4% dH2O).
Spironolactone (Sigma, St Louis, MO, USA) was dissolved in
ethanol at 25 mg/ml and added to drinking water. Mice received
spironolactone at a dose of 20 mg/kg/day.20
Blood analysis
Blood was drawn from the retroorbital sinus under light ether
anesthesia. Serum electrolyte concentration was measured by i-
STAT.15 Serum aldosterone levels were measured by the SRL clinical
laboratory service (Tokyo, Japan).
Immunoblotting and immunofluorescence
Semiquantitative immunoblotting was performed as previously
described15 to assess the relative expression levels of the proteins of
interest in whole homogenate without the nuclear fraction (600 g) or
the crude membrane fraction (17,000 g) from whole kidneys. Whole
homogenates were prepared in lysis buffer containing phosphatase
inhibitors. The band intensity was analyzed with ImageGauge
software (Fujifilm, Tokyo, Japan). For the immunofluorescence
assay, kidneys were fixed by perfusion through the left ventricle with
periodate lysine (0.2 M) and paraformaldehyde (2%) in phosphate-
buffered saline. Tissue samples were soaked for several hours in 20%
sucrose in phosphate-buffered saline, embedded in Tissue-Tek OCT
Compound (Sakura Finetechnical Co., Ltd., Tokyo, Japan), and snap
frozen in liquid nitrogen. The following primary antibodies were
used: rabbit anti-WNK4 (1:200) (Alpha Diagnostic, San Antonio,
TX, USA), rabbit anti-WNK1 (1:200) (Novus Biologicals, Littleton,
CO, USA), rabbit anti-NCC (1:200) (Chemicon, Temecula, CA,
USA), rabbit anti-OSR1/SPAK and rabbit anti-p-OSR1 (Ser325)/
SPAK (Ser380) antibodies (11), rabbit anti-p-NCC (Ser71) anti-
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Figure 7 | Proposed model of WNK-OSR1/SPAK-NCC cascade in
distal tubules. Phosphorylations of OSR1/SPAK and NCC were
shown to be regulated by aldosterone in the present study. As the
phosphorylation of OSR1/SPAK was monitored at the specific
phosphorylation sites by WNK kinases (reference 17), increased
phosphorylation of OSR1/SPAK indicates increased WNK activity.
Although the in vitro phosphorylation assay revealed that both
wild-type WNK1 and WNK4 increased phosphorylation of OSR1/
SPAK, it is not clear which WNK kinase mediates this aldosterone
action to OSR1/SPAK and NCC. The role of other WNK (WNK3) or
multiple WNK complexes (reference 22) in the phosphorylation of
OSR1/SPAK and NCC also remains to be determined. Mechanisms
by which aldosterone activates WNK are also unclear. WNK4 is
reported to be phosphorylated by SGK (reference 23), but
whether this phosphorylation increases the phosphorylation of
OSR1/SPAK has not been determined.
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body,15 and mouse antiparvalbumin and calbindin antibodies
(Swant, Bellinzona, Switzerland). We generated two more antibodies
to specifically recognize p-NCC at Thr53 and Thr58 by immunizing
rabbits with a keyhole limpet hemocyanin-conjugated synthetic
phosphopeptide corresponding to residues 49–57 and 54–63 of
mouse NCC (LYMRpTFGYN and FGYNpTIDVVP). The serums
were affinity purified with the antigen phosphopeptides and then
immunoabsorbed against the corresponding nonphosphopeptide.
Phosphospecificity of the antibodies was verified by the antigen
absorption test and the disappearance of the bands after phospha-
tase treatment (Supplementary Figure 4). In the immunoblot of
total OSR1/SPAK, each OSR1 and SPAK signal appeared as multiple
bands in the mouse kidney homogenates (Figure 3). Although the
identity of each band has not yet been clarified, all of the bands
disappeared after the antigen absorption test,15 indicating that they
may be splice variants of OSR1 and SPAK. Alkaline-phosphatase-
conjugated anti-IgG antibodies (Promega, Madison, WI, USA) were
used as secondary antibodies for immunoblotting, and Alexa 488 or
546 dye-labeled (Invitrogen, Carlsbad, CA, USA) secondary
antibodies were used for immunofluorescence. Immunofluorescence
images were obtained by LSM510 Meta (Carl Zeiss, Gottingen,
Germany).
Statistical methods
Statistical significance was tested by one-way analysis of variance
followed by Fischer’s post hoc test. P-values less than 0.05 were
considered statistically significant.
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